- October 9, 2018 at 4:04 am #2148daprofKeymasterCredits: 486
What is the Bexel Irina Technology?
The Bexel Technology was first developed through collaboration between several Russian and Korean scientists in 1997.
A well known established Korean company named STC (known for their mass development of batteries and Gillette razors) became involved in a joint venture with the Korean Government who then rigorously established the Bexel Irna iridological research and development protocal based at the The Peoples’ Friendship University of Russia.
Much of the basis of this technology was founded upon Russia’s most prestigious iridologist, Dr. Velchover.
Most special about the Bexel Irina technology is that the topographical chart used in the software is placed accurately on every unique eye, thus, every chart is unique to each set of eyes.
The Bexel system was the only iridological analysis system that ever successfully achieved FDA approved status as medical device class 3 in Korea, following the highly successful Korean government certified clinical studies held at AJU University.
You can read the results of the Bexel Clinical Hospital Study here: Bexel Irina Clinical Study – Aju University
Following the collapse of Asian economics back in 1998, the Bexel Irina never did make it to the North American or European market. However, a few systems were sold to some hospitals located along the Asian rim.
Why is the Bexel Irina Technology still useful to Iridology?
The Bexel Irina technology is based on eye bio-metrics and offers very valuable mathematical parameters of the pupil and collarette. These mathematical parameters are very important in verifying changes in the autonomic nervous system that can be used for clinical studies and determining ACTUAL changes in the human eye, including patient health improvement or an ongoing pathology. Clinical studies require strong scientific evidence and the Bexel Irina can deliver that scientific data!
In the past, many iridologists made the mistake of determining current health pathology based upon various signs in the iris including lacunae. As we now understand, lacunae are genotypic, do not change in density, thus do not always represent active disease pathology. However, when there are associated signs with lacunae such as collarette or pupil deformations, the iridologist can establish an active pathology associated with genetic weakness (lacunae). In other words, if your patient successfully achieves a health protocol with notable improvement, you will not see ‘healing lines’ in lacunae, but you should see positive changes in the pupillary parameters. And the changes in pupil can be scientifically proven with the Bexel Irina mathematical parameter data.
For the iridologist, it is very difficult to determine the several degrees of pupil deformations, decentrations and multiformaties. For example, pupillary flatness, not less than one sixth of pupil circumference, is considered to be significant in showing active pathology. For a human to detect this degree of flatness would be a very difficult task!
STC (Suttong) invested over 10 million USD into the Bexel Irina development. The Bexel system displayed in attached images was offered to hospitals at 35K USD. It would be a shame if this technology was forgotten and why Iridology Research will be offering this amazing technology to its members via remote access. At this time, we will be offering the Bexel Irina using remote access since it is very difficult to rebuild these systems. If the demand increases for access to this technology, we are able to build several more Bexel irina systems to be available for remote access use.
You must be logged in to access attached files.
- You must be logged in to reply to this topic.